| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0008 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |